← All peptides
Longevity & Anti-aging
Healing & Recovery
Research Chemical

Vesugen

Also known as: Vesugen

Vesugen is a short tripeptide bioregulator studied for support of the vascular system and blood-vessel wall integrity. It is part of the Khavinson peptide family aimed at tissue-specific regulation.

Last updated

Mechanism of Action

Vesugen (Lys-Glu-Asp) is a synthetic peptide bioregulator proposed to act on the endothelium and vascular smooth muscle. It is suggested to influence tissue-specific gene expression that supports vessel-wall structure and normalizes endothelial function. By modulating protein synthesis in vascular cells it is associated with improved microcirculation and resistance to age-related vascular decline. Its mechanism follows the broader Cytomax hypothesis of restoring physiological cell function in a target tissue.

Half-life
Short, on the order of minutes for the free tripeptide
Administration Routes
subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Supports vascular wall integrity
  • May improve endothelial function
  • Promotes healthy microcirculation
  • Investigated for age-related vascular support
  • Part of the short-peptide bioregulator class

Potential Side Effects

  • Possible injection-site reaction
  • Limited human clinical data
  • Unknown long-term safety

Common Dosing

For research use only: Khavinson-type peptides are commonly referenced in short microgram-range research courses; no validated human dosing exists. Not personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Pregnancy and breastfeeding
  • Known peptide hypersensitivity
  • [Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging]

    2014

    View
  • [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION]

    2015

    View
  • Peptides tissue-specifically stimulate cell differentiation during their aging

    2012

    View
  • Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation

    2022

    View

It is a vascular-directed short peptide bioregulator studied for support of blood-vessel walls and endothelial function.

No. It is a research-chemical peptide bioregulator and lacks robust human clinical validation.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.